Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
68,885.82
(
-2.31%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: oc631 post# 139846

Thursday, 04/05/2012 7:55:12 PM

Thursday, April 05, 2012 7:55:12 PM

Post# of 257268

If GS-7977/Riba lacks potency in GT1/GT1A do you think GILD would partner with BMY or Tibotec as opposed to focusing only on an in-house combo?

Keep in mind, GILD already has the planned GS-7977/TMC435 combo study with Tibotec/Medivir.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today